Tianjin Zhong Xin Pharmaceutical Group Corp

Tianjin Zhing Xin Pharma records 1Q21 earnings jump of 25% y-o-y to $44 million - THE EDGE SINGAPORE

Results

Tianjin Zhong Xin Pharma records 1Q21 earnings jump of 25% y-o-y to $44 million

Tianjin Zhong Xin Pharmaceutical Group Corporation has reported earnings of RMB213 million ($43.5 million) for its 1QFY2021 ended March, up 25% y-o-y.

SGX query

Tianjin Zhong Xin Pharmaceutical triggers SGX query as shares increase by over 10%

Singapore Exchange Regulation (SGX RegCo) has issued a query to Tianjin Zhong Xin Pharmaceutical regarding “unusual price movements” in its shares on Dec 17.

Malaysian glove maker UG Healthcare wins for overall sector - THE EDGE SINGAPORE

Billion Dollar Club 2020

Malaysian glove maker UG Healthcare wins for overall sector

In a sign of how glove makers are enjoying their day in the sun, the Centurion Club overall sector winner for Healthcare Services & Pharmaceuticals goes to another Malaysia-based glove maker,

Broker's Calls

'Buy' Tianjin Zhong Xin as TCM demand could rebound strongly: UOB Kay Hian

Despite the impact from the novel coronavirus (Covid-19) lockdown measures, UOB KayHian is still bullish on Tianjin Zhong Xin Pharmaceutical Group Corp.

×